The HTC was founded in 1973 in order to provide a permanent research and treatment facility for patients with bleeding and clotting disorders. For more than 40 years, the HTC has managed Comprehensive Hemophilia Clinics from a variety of locations throughout the University of Colorado campus. These clinics offer services that have improved the quality of life for thousands of people living with bleeding disorders. In April 2011, the HTC moved to space in the University Physicians, Inc. (UPI) building just north of the main Anschutz Medical Campus to accommodate the needs of our patients.
It was not long ago that bleeding and clotting disorders often resulted in early death. The HTC has made significant advances in the treatment of a disorder that previously crippled joints and prevented patients from attending school, maintaining employment and living a normal life. The HTC has expanded in recent years to provide specialized research and care for patients with pediatric stroke in addition to those with hemophilia and thrombosis. In April 2012, the HTC entered into a contractual relationship with Children's Hospital Colorado and its Center for Cancer and Bleeding Disorders (CCBD) to manage the clinic portion of the HTC. This alliance offers patients research, experience and resources from the region's top institutions of learning and patient care.
Our hope for the future is that the development of gene therapy will free people with bleeding disorders from the need for continuous treatment. Until that time, the HTC will continue as an international leader in the development and implementation of treatments for those living with bleeding disorders. We at the HTC strive to provide top quality services, programs, and research that will allow those affected to live more healthy and active lives.